Literature DB >> 17001501

Characterization of matrix metalloproteinase expressed by human embryonic kidney cells.

Chi-Hsien Liu1, Pel-Shan Wu.   

Abstract

There is little information available on the proteases expressed by human embryonic kidney (HEK) cells, which are often used for expression of recombinant proteins and production of adenovirus vector. The expression profile of proteases in HEK cell line was investigated using zymography, mRNA analysis, western blotting and protein array. The major protease was gelatinase A [or matrix metalloproteinase (MMP)-2]. Beside, other MMPs, such as MMP-1, -2, -3, -8, -9, -10, -13 and membrane type (MT) 1- and 3-MMP, as well as tissue inhibitors of metalloproteinase (TIMP)-1, -2 and -3, were also expressed by HEK cells. Characterization of MMP and TIMP profiles expressed by HEK cells provides the basis for degradation control of recombinant protein and adenovirus vector during culture and purification processes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17001501     DOI: 10.1007/s10529-006-9147-y

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  3 in total

1.  QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue.

Authors:  Jia Zhou; Peng Tao; Jed F Fisher; Qicun Shi; Shahriar Mobashery; H Bernhard Schlegel
Journal:  J Chem Theory Comput       Date:  2010-11-09       Impact factor: 6.006

2.  Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.

Authors:  Peng Tao; Jed F Fisher; Qicun Shi; Thom Vreven; Shahriar Mobashery; H Bernhard Schlegel
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

3.  Soluble Ectodomain of Neuroligin 1 Decreases Synaptic Activity by Activating Metabotropic Glutamate Receptor 2.

Authors:  Michelle D Gjørlund; Eva M M Carlsen; Andreas B Kønig; Oksana Dmytrieva; Anders V Petersen; Jacob Jacobsen; Vladimir Berezin; Jean-François Perrier; Sylwia Owczarek
Journal:  Front Mol Neurosci       Date:  2017-05-03       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.